A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

Yoshihito Kogure,Hideo Saka,Yuichi Takiguchi,Shinji Atagi,Takayasu Kurata,Noriyuki Ebi,Akira Inoue,Kaoru Kubota,Mitsuhiro Takenoyama,Takashi Seto,Akiko Kada,Takeharu Yamanaka,Masahiko Ando,Nobuyuki Yamamoto,Akihiko Gemma,Yukito Ichinose

Clinical Lung Cancer（2018）

引用 7|浏览0

暂无评分

摘要

If OS is greater in patients treated with CBDCA with nab-PTX than with DOC, this study will provide a new standard of care for elderly patients with squamous NSCLC.

查看译文

关键词

Chemotherapy,Combination therapy,NSCLC,Overall survival,Single agent

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要